Wall Street analysts expect Markel Co. (NYSE:MKL) to report sales of $1.60 billion for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Markel’s earnings, with estimates ranging from $1.55 billion to $1.68 billion. Markel posted sales of $1.39 billion during the same quarter last year, which would indicate a positive year over year growth rate of 15.1%. The company is scheduled to report its next earnings report on Wednesday, April 25th.
On average, analysts expect that Markel will report full year sales of $1.60 billion for the current fiscal year, with estimates ranging from $6.43 billion to $6.86 billion. For the next financial year, analysts anticipate that the firm will post sales of $6.88 billion per share, with estimates ranging from $6.66 billion to $7.23 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that follow Markel.
Markel (NYSE:MKL) last announced its quarterly earnings data on Tuesday, February 6th. The insurance provider reported $6.64 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $8.55 by ($1.91). Markel had a net margin of 6.52% and a return on equity of 0.39%. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.58 billion.
Shares of Markel (NYSE:MKL) traded down $5.39 during midday trading on Wednesday, hitting $1,139.61. 17,209 shares of the stock traded hands, compared to its average volume of 31,670. Markel has a one year low of $936.95 and a one year high of $1,157.30. The stock has a market cap of $15,840.00, a PE ratio of 814.01 and a beta of 0.95. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.60 and a quick ratio of 0.60.
In related news, insider Alan I. Kirshner sold 100 shares of Markel stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $1,133.50, for a total transaction of $113,350.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Vice Chairman Steven A. Markel sold 200 shares of Markel stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $1,143.47, for a total transaction of $228,694.00. Following the transaction, the insider now owns 106,360 shares in the company, valued at approximately $121,619,469.20. The disclosure for this sale can be found here. Insiders have sold a total of 1,800 shares of company stock worth $1,999,650 in the last 90 days. Company insiders own 2.53% of the company’s stock.
Large investors have recently bought and sold shares of the stock. BlackRock Inc. lifted its holdings in shares of Markel by 0.3% during the 4th quarter. BlackRock Inc. now owns 845,404 shares of the insurance provider’s stock valued at $963,025,000 after acquiring an additional 2,155 shares in the last quarter. California Public Employees Retirement System lifted its holdings in shares of Markel by 3.4% during the 3rd quarter. California Public Employees Retirement System now owns 29,434 shares of the insurance provider’s stock valued at $31,435,000 after acquiring an additional 968 shares in the last quarter. State of Wisconsin Investment Board lifted its holdings in shares of Markel by 4.4% during the 3rd quarter. State of Wisconsin Investment Board now owns 12,614 shares of the insurance provider’s stock valued at $13,471,000 after acquiring an additional 533 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Markel by 1.4% during the 3rd quarter. Wells Fargo & Company MN now owns 76,310 shares of the insurance provider’s stock valued at $81,497,000 after acquiring an additional 1,022 shares in the last quarter. Finally, Rhumbline Advisers lifted its holdings in shares of Markel by 4.3% during the 3rd quarter. Rhumbline Advisers now owns 16,470 shares of the insurance provider’s stock valued at $17,590,000 after acquiring an additional 676 shares in the last quarter. Institutional investors and hedge funds own 78.13% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3258260/zacks-brokerages-expect-markel-co-mkl-will-post-quarterly-sales-of-1-60-billion.html.
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.